InMed Pharmaceuticals Inc INM

Healthcare Cannabis

InMed Pharmaceuticals Inc. is a pharmaceutical company. It develops a pipeline of small molecule drug candidates targeting the CB1/CB2 receptors. Its InMed Pharmaceuticals segment is engaged in the research and development of small molecule pharmaceuticals drug candidates. Its BayMedica Commercial segment is engaged in the manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its pharmaceutical pipeline consists of three programs, with drug candidates targeting Alzheimer’s disease, dry age-related macular degeneration, and Epidermolysis Bullosa. Its INM-901 is a drug candidate being developed as a potential treatment for Alzheimer’s disease. Its INM-089 is cannabinoid analog being studied for its potential as a treatment for age-related macular degeneration. Its INM-755 is a cannabinol topical cream which has completed Phase 2 clinical trial studies for the treatment of epidermolysis bullosa.

NDAQ:INM - Post by User

InMed Pharmaceuticals Inc

Bullboard Posts

Comment by RedDeerMoneymanon Jan 17, 2017 3:45pm

282 Views

Post# 25719021

RE:HUGE day today +56%!!!

Tomorrow we should gap up well over 50 cents and then we can get rid of this half cent BS
That will really move this nicely.

With the movement in the past few days inmed should have no problem preparing the patients for clinical trials in Ontario.
We should also see the formulation patent for EB a lot sooner than later.

2017 is going to be a huge mover for Inmed.

Don't want to sound like a pumper, I'm just so damn Happy.

Bullboard Posts

Revolutionary inverter technology leads the clean energy charge